Patents by Inventor Vikram Virdi

Vikram Virdi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Means and methods for oral protein delivery
    Patent number: 11964002
    Abstract: The present invention relates to the field of recombinant protein production in a host cell. More specifically the invention relates to the field of oral protein delivery. Specifically, the invention provides oral pharmaceutical formulations comprising the culture medium of a recombinant host secreting a recombinant protein. The resulting oral pharmaceutical formulations are useful for the treatment of gastro-intestinal and/or buccal disorders. Additionally, the oral pharmaceutical formulations are useful for prophylactic and vaccine purposes.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: April 23, 2024
    Assignees: VIB VZW, Universiteit Gent
    Inventors: Nico Callewaert, Robin Vanluchene, Bram Laukens, Anna Depicker, Vikram Virdi
  • Protective anti-ETEC antibody
    Patent number: 10829546
    Abstract: This disclosure relates to an antibody that can protect against ETEC infection in a passive immunization set up. More specifically, it relates to a VHH grafted on an IgA scaffold and produced in plant seeds. When the seeds are given in food or feed, the subject is protected against ETEC infection.
    Type: Grant
    Filed: September 3, 2013
    Date of Patent: November 10, 2020
    Assignees: VIB VZW, Universiteit Gent, Vrije Universiteit Brussel
    Inventors: Anna Depicker, Henri De Greve, Vikram Virdi
  • MEANS AND METHODS FOR ORAL PROTEIN DELIVERY
    Publication number: 20200009229
    Abstract: The present invention relates to the field of recombinant protein production in a host cell. More specifically the invention relates to the field of oral protein delivery. Specifically, the invention provides oral pharmaceutical formulations comprising the culture medium of a recombinant host secreting a recombinant protein. The resulting oral pharmaceutical formulations are useful for the treatment of gastro-intestinal and/or buccal disorders. Additionally, the oral pharmaceutical formulations are useful for prophylactic and vaccine purposes.
    Type: Application
    Filed: February 28, 2018
    Publication date: January 9, 2020
    Inventors: Nico Callewaert, Robin Vanluchene, Bram Laukens, Anna Depicker, Vikram Virdi
  • PROTECTIVE ANTI-ETEC ANTIBODY
    Publication number: 20150252100
    Abstract: This disclosure relates to an antibody that can protect against ETEC infection in a passive immunization set up. More specifically, it relates to a VHH grafted on an IgA scaffold and produced in plant seeds. When the seeds are given in food or feed, the subject is protected against ETEC infection.
    Type: Application
    Filed: September 3, 2013
    Publication date: September 10, 2015
    Applicant: Vrije Universiteit Brussel
    Inventors: Ann De Picker, Henri De Greve, Vikram Virdi